LONG TERM (5 YEARS) OUTCOMES IN PATIENTS WITH UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS TREATED WITH DRUG-ELUTING STENT IMPLANTATION: A SINGLE CENTER EXPERIENCE.  by Magni, Valeria et al.
    
 i2 SUMMIT   
A200.E1880 
JACC March 9, 2010
Volume 55, issue 10A
LONG TERM (5 YEARS) OUTCOMES IN PATIENTS WITH UNPROTECTED LEFT MAIN CORONARY ARTERY 
STENOSIS TREATED WITH DRUG-ELUTING STENT IMPLANTATION: A SINGLE CENTER EXPERIENCE.
i2 Poster Contributions
Georgia World Congress Center, Hall B5
Monday, March 15, 2010, 9:30 a.m.-10:30 a.m.
Session Title: Intravascular Diagnostics and Complex Lesions
Abstract Category: PCI - Complex Lesions
Presentation Number: 2503-438
Authors: Valeria Magni, Alaide Chieffo, Alfonso Ielasi, Matteo Montorfano, Azeem Latib, Cosmo Godino, Mauro Carlino, Iassen Michev, Antonio 
Colombo, San Raffaele Hospital, Milan, Italy, EMO GVM Centro Cuore Columbus, Milan, Italy
Background: Encouraging results have been reported at mid-term clinical follow-up in some observational registries with elective drug-eluting 
stent (DES) implantation in left main coronary artery (LMCA). Results from LMCA subset of the Syntax trial showed that revascularization with PCI has 
comparable safety and efficacy outcomes to CABG.
Methods: All consecutive patients who underwent elective implantation of either sirolimus- (SES) or paclitaxel-eluting stent (PES) for de novo LMCA 
lesions between March 2002 and June 2004 were analyzed.
Results: A total of 107 pts were treated: 52 with PES and 55 with SES implantation. High mortality risk scores (Euroscore >6) were present in 34 
(31.7%) of the pts. Eighty-seven (81.3%) patients had a distal left main lesion location. A double stent technique was preferred in 64 (73.6%) pts: ‘crush’ 
technique was performed in 38 (59.4%) of them. Procedural success was achieved in all pts. During hospitalization none of the patient had a Q wave 
MI, died or underwent CABG. Angiographic follow-up performed in 93 pts (86.9%). At 5 years, 17 (15.9%) patients died; among them 8 (7.5%) were 
adjudicated as cardiac deaths according to ARC definition. Six of the cardiac deaths could be considered as possible late stent thrombosis (ST). Only 1 
pt had a definite late ST at 3.9 months while on double antiplatelet therapy (DAT). TVR (defined as any revascularization in left coronary system) occurred 
in 30 (28.0%) pts (24 re-PCI and 6 CABG) and TLR (defined as any revascularization in the stented segment) in 20 (18.7%); all of them occurred in pts 
with treatment of distal LMCA. At 5-year follow-up freedom from MACCE without new revascularizations was 82.4%.
Conclusions: Treatment of LMCA stenosis with DES appears to be safe and with favorable clinical outcomes maintained at very long term (five 
years) clinical follow-up.
